After bombarding Latin-America with several e-mails presenting the approval of Hemoxin, one of the main papers in the capital decided to publish my letter verbatim! Though that was not my intention, at least they have the news.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.